Revenue
attach_money63M USD
YoY +18.8%
SRNESorrento Therapeutics, Inc.$ --
Sorrento Therapeutics, Inc.
SRNE
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2022 Full YearUpdated: 12/31/2022
Operating Income
bar_chart-504M USD
YoY -37.0%
Net Income
verified-573M USD
YoY -33.5%
EPS
pie_chart-1.37USD
YoY +6.2%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress47.6%Below Target
Revenue Progress31.3M
Revenue Forecast24.7M
Net Income Progress-234.8M
Net Income Forecast-493.2M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.